Rhinosinusitis clinical trials

Explore recruiting rhinosinusitis clinical trials.

Recruiting rhinosinusitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rhinosinusitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: the effect on comorbid eosinophilic otitis media

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Direct comparison of Tezepelumab and Dupilumab in CRSwNP in a real world setting

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of Tezepelumab on barrier function in severe asthmatic patients with and without comorbid chronic rhinosinusitis with nasal polyps – an exploratory study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Actisoufre nasal spray in a pressurized container compared to placebo in female and male adult and paediatric population over 6 years old with acute rhinitis, rhinopharyngitis and rhinosinusitis not requiring antibiotic therapy.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rhinosinusitis trials by city

Rhinosinusitis in Toronto Rhinosinusitis in Vancouver Rhinosinusitis in Montreal Rhinosinusitis in Calgary Rhinosinusitis in Edmonton Rhinosinusitis in Ottawa Rhinosinusitis in Winnipeg Rhinosinusitis in Quebec City Rhinosinusitis in Hamilton Rhinosinusitis in Kitchener Rhinosinusitis in London Rhinosinusitis in Halifax Rhinosinusitis in New York Rhinosinusitis in Los Angeles Rhinosinusitis in Chicago Rhinosinusitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease